You are unauthorized to view this page. Username Password Remember Me Forgot Password
Frazier Healthcare Partners Announces Acquisition of EPTAM Precision Solutions Read More »
You are unauthorized to view this page.
J.H. Whitney Announces the Sale of Accupac Read More »
J.H. Whitney Capital Partners, LLC, a leading private equity investment firm, is pleased to announce the sale of its portfolio company Accupac, Inc. (“Accupac” or the “Company”) to Palladium Equity Partners. Accupac is a leading U.S. provider of outsourced manufacturing and packaging solutions to the world’s largest personal care product, pharmaceutical, and over-the-counter (OTC) drug
J.H. Whitney Announces the Sale of Accupac Read More »
Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products announced Tuesday that it has completed the acquisition of Cobra Biologics, a leading CDMO specialized in providing development and manufacturing services for plasmid DNA and viral vector. Existing Cognate shareholder, EW Healthcare Partners and its co-investors led
Cognate BioServices Closes Series B and Completes Acquisition of Cobra Biologics Read More »
Frazier Healthcare Partners (“Frazier”) today announced the acquisition of EPTAM Precision Solutions (“EPTAM” or the “Company”) and the appointment of Frazier Operating Partner, Mark Kemp, as CEO. The transaction closed in December 2019; terms of the deal were not disclosed. Founded in 1981, EPTAM is a diversified outsourced manufacturer of medical device and other high
Frazier Healthcare Partners Announces Acquisition of EPTAM Precision Solutions Read More »
Alcami Corporation (“Alcami”), a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, announced Friday it has acquired TriPharm Services (“TriPharm”), a new state-of-the-art sterile fill-finish manufacturing center located near Research Triangle Park, North Carolina. The acquisition of TriPharm follows the recently announced $17 million expansion of Alcami’s sterile fill-finish facility
Alcami Expands its Sterile Fill-Finish Capacity with Acquisition of TriPharm Services Read More »
Sinclair Research, a leading provider of nonclinical contract research services, today announced an agreement to acquire the assets of the GLP safety pharmacology business unit of CorDynamics, a premier provider of cardiovascular toxicology and safety pharmacology contract research services. In addition to being able to support safety pharmacology core battery assessments of cardiovascular, respiratory and
